These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Clinical trial of a new drug, analog of chlordiazepoxide, for treatment of anxiety and tension. Gilbert MM Int J Neuropsychiatry; 1965 Dec; 1(6):556-8. PubMed ID: 5886535 [No Abstract] [Full Text] [Related]
24. Valproate pretreatment for the difficult-to-treat patient with OCD. Deltito JA J Clin Psychiatry; 1994 Nov; 55(11):500. PubMed ID: 7989288 [No Abstract] [Full Text] [Related]
25. A new antidepressant agent: amitriptyline-N-oxide. Borromei A Adv Biochem Psychopharmacol; 1982; 32():43-7. PubMed ID: 7046367 [No Abstract] [Full Text] [Related]
30. [Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine]. Servant D; Bailly D; Le Seac'h H; Parquet PJ Encephale; 1990; 16 Spec No():359-62. PubMed ID: 2120029 [TBL] [Abstract][Full Text] [Related]
31. Urinary MHPG is not a good predictor of antidepressive drug response. Puzyński S; Rode A; Bidziński A; Mrozek S; Załuska M Pol J Pharmacol Pharm; 1984; 36(4):329-35. PubMed ID: 6527968 [TBL] [Abstract][Full Text] [Related]
32. [Further observations on the effects of the treatment with amitriptyline and perphenazine in essential headache]. Pisani RA; Lazzari R; Franzese A; Arzilli A Clin Ter; 1987 Sep; 122(5):345-50. PubMed ID: 2972451 [No Abstract] [Full Text] [Related]
33. Antiobsessional and antidepressant effects of clomipramine in the treatment of obsessive-compulsive disorder. Insel TR; Alterman I; Murphy DL Psychopharmacol Bull; 1982 Oct; 18(4):115-7. PubMed ID: 7156271 [No Abstract] [Full Text] [Related]
35. [The role of drug therapy in the treatment of obsessive-compulsive disorders]. Teeuwisse JM; Nolen WA Ned Tijdschr Geneeskd; 1989 Dec; 133(52):2605-8. PubMed ID: 2575230 [No Abstract] [Full Text] [Related]
36. [Efficacy assessment of fluoxetine treatment of outpatients with obsessive-compulsive disorder: a preliminary report]. Wandzel L Psychiatr Pol; 1997; 31(4):429-35. PubMed ID: 9527686 [TBL] [Abstract][Full Text] [Related]
37. Imipramine and placebo in the treatment of obsessive-compulsives: their effect on depression and on obsessional symptoms. Foa EB; Steketee G; Kozak MJ; Dugger D Psychopharmacol Bull; 1987; 23(1):8-11. PubMed ID: 3602334 [No Abstract] [Full Text] [Related]